You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Potent Anti-Myeloma Effect

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Italy, Switzerland (Nelfinavir, Lenalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Milano, Italy
  • +10 more
Jul 4, 2022

HIV Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452), HIV-1 Immunogen)

Completed
  • HIV Infections
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • HIV-1 Immunogen
  • Los Angeles, California
  • +16 more
Oct 28, 2021

Based on PRO Data Reported ThroughMHealth App Solution in

Completed
  • Multiple Myeloma
  • mHealth app
  • Odense, Denmark
    Odense University Hospital
Feb 10, 2023

New Echocardiographic Indicators in Treatment of Primary

Not yet recruiting
  • Multiple Myeloma
  • Chemotherapy and/or autologous hematopoietic stem cell transplantation
  • (no location specified)
Sep 18, 2023

Osteoporosis, Postmenopausal Trial in Kennesaw (Quercetin (500 mg), Placebo (500 mg))

Completed
  • Osteoporosis, Postmenopausal
  • Quercetin (500 mg)
  • Placebo (500 mg)
  • Kennesaw, Georgia
    Kennesaw State University
May 7, 2022

Plasma Cell Myeloma Trial in Philadelphia (Daratumumab and Hyaluronidase-fihj, Questionnaire Administration, Quality-of-Life

Not yet recruiting
  • Plasma Cell Myeloma
  • Daratumumab and Hyaluronidase-fihj
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 19, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (drug, biological, other)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Des Moines, Iowa
  • +8 more
Jan 12, 2023

Multiple Myeloma, High-Risk Cancer Trial in Montreal (Bortezomib following nonmyeloablative allogeneic transplant)

Active, not recruiting
  • Multiple Myeloma
  • High-Risk Cancer
  • Bortezomib following nonmyeloablative allogeneic transplant
  • Montreal, Quebec, Canada
    Hôpital Maisonneuve-Rosemont
Aug 22, 2022

Multiple Myeloma Trial in Hackensack (Pembrolizumab, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Hackensack, New Jersey
    John Theurer Cancer Center-Hackensack Meridian Health
Jan 18, 2022

Multiple Myeloma Trial in Nantong (Colchicine, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Nantong, Jiangsu, China
    Affiliated Hospital of Nantong University
Mar 25, 2023

Multiple Myeloma in Remission Trial in Shenzhen, Haikou (MM-specific universal CAR T cells)

Recruiting
  • Multiple Myeloma in Remission
  • MM-specific universal CAR T cells
  • Shenzhen, Guangdong, China
  • +1 more
Aug 23, 2023

HIV Trial in United States (Aldesleukin)

Completed
  • HIV Infections
  • Los Angeles, California
  • +16 more
Oct 28, 2021

Multiple Myeloma Trial (Melphalan and Treosulfan, Melphalan)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Dec 5, 2022

Selinexor in Relapsed or Refractory Multiple Myeloma - SEATTLE-

Recruiting
  • Multiple Myeloma
  • Wien, Austria
  • +1 more
Jul 13, 2023

Caused by Anti-CGRP mAbs in Migraine Patients Treated With

Recruiting
  • Migraine Disorders
  • Diagnostic radiology
  • Lugano, Ticino, Switzerland
    Chiara ZECCA
Sep 6, 2023

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial (Elotuzumab, Selinexor, and Dexamethasone (ESd))

Withdrawn
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Elotuzumab, Selinexor, and Dexamethasone (ESd)
  • (no location specified)
Apr 27, 2022

Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

Completed
Has Results
  • Myeloproliferative Disorders
  • +4 more
  • T-cell replete PBPC allograft
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022

Relapsed/Refractory Multiple Myeloma Trial in Benowa (ISB 2001)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • ISB 2001
  • Benowa, Queensland, Australia
    Pindara Private Hospital
May 18, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 24, 2023

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Bone Marrow Biopsy
  • +3 more
  • Phoenix, Arizona
  • +2 more
Jan 18, 2023

Multiple Myeloma, Myeloma, Myeloma Multiple Trial in United States (KTX-1001)

Recruiting
  • Multiple Myeloma
  • +2 more
  • Scottsdale, Arizona
  • +5 more
Jan 12, 2023

Recurrent Plasma Cell Myeloma Trial in Jacksonville (Dexamethasone, Laboratory Biomarker Analysis, Lenalidomide)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

Multiple Myeloma Trial run by the National Cancer Institute (NCI) (Dexamethasone, Carfilzomib, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Migraine Without Aura Trial in Copenhagen (Levcromakalim, Placebo)

Recruiting
  • Migraine Without Aura
  • Copenhagen, Denmark
    Danish Headache Center
May 25, 2023

Migraine Without Aura Trial in Copenhagen (Sildenafil, Placebo)

Recruiting
  • Migraine Without Aura
  • Copenhagen, Denmark
    Danish Headache Center
May 25, 2023